Ignite Creation Date:
2024-05-06 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05064852
Status:
UNKNOWN
Last Update Posted:
2021-10-01
First Post:
2021-09-21
Brief Title:
A Real-world Study of the Safety and Efficacy of Surufatinib in the Treatment of Biliary Tract Carcinoma
Sponsor:
Qilu Hospital of Shandong University
Organization:
Qilu Hospital of Shandong University
Organization Data
Organization:
Qilu Hospital of Shandong University
Class:
OTHER
Study ID:
HMPL-012-RWS-BTC101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Qilu Hospital of Shandong University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None